CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in LGND — Ligand Pharmaceuticals Inc
CIK 884546
SAN FRANCISCO, CA
Position in LGND
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$61,080,599
+$24,567,210 QoQ
Shares Held
193,238
+5.7% QoQ
Ownership
0.969%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#28
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,402,603,842 across 299 Biotechnology names. LGND ranks #29 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,041,282 | $1,013,966,007 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
846,306 | $527,705,642 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
1,917,025 | $359,020,441 | |
| 4 | MRNA |
Moderna, Inc.
|
4,838,884 | $338,867,045 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
755,377 | $227,391,137 | |
| 6 | INCY |
Incyte Corp
|
1,692,439 | $191,854,884 | |
| 7 | RPRX |
Royalty Pharma plc
|
3,083,528 | $172,893,414 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,565,781 | $133,388,883 |
All Filings in LGND
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $61,080,599 | 193,238 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $36,513,389 | 182,887 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $34,842,575 | 184,284 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $32,295,279 | 182,315 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $20,014,955 | 176,064 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $17,755,412 | 168,874 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $18,260,395 | 170,419 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $16,407,153 | 163,924 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,088,948 | 155,340 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $10,948,625 | 149,776 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $11,532,901 | 161,480 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $9,418,645 | 157,187 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $11,134,114 | 154,426 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $10,823,103 | 147,133 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $11,264,216 | 168,626 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $13,827,278 | 160,577 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $14,191,679 | 159,064 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $17,377,574 | 154,481 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $23,665,272 | 153,213 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $20,028,355 | 143,758 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $17,995,725 | 137,173 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $19,746,232 | 129,526 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $12,043,887 | 121,105 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $11,468,138 | 120,312 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,531,284 | 103,096 | Shares | Sole | 2020-08-20 | |
| 2020-03-31 | $7,568,763 | 104,081 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||